secwatch.observer — SEC 8-K summary
======================================

Issuer:     COOPER COMPANIES, INC. (COO)
CIK:        0000711404
Form:       8-K
Filed at:   2025-12-23T23:59:59+00:00
Accession:  0001193125-25-331117
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CooperCompanies appoints former STERIS CEO Rosebrough to board; agrees with Browning West
--------------------------------------------------------------------------------

- Walter M. Rosebrough Jr., former STERIS CEO, appointed as independent director effective Jan 3, 2026; joins Governance & Nominating Committee.
- Board will consider appointing Rosebrough as Chair by end of 2026 and add another independent director with medtech experience by June 30, 2026, subject to Browning West approval.
- Cooperation agreement with Browning West includes customary standstill and voting commitments through 30 days before 2027 annual meeting deadline.
- Rosebrough led STERIS from 2007-2021, delivering 18% annualized total return and growing market cap by over $20B.
- Incoming Board Chair Colleen Jay welcomes the appointment; Browning West's CIO Usman Nabi calls it a constructive path forward.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/711404/000119312525331117/0001193125-25-331117-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/711404/000119312525331117/d96045d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-331117

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer